Axsome Therapeutics, Inc.
Pharmaceutical company · New York, United States · Nasdaq: AXSM
Axsome Therapeutics, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker AXSM. It has reported private securities offerings to the US SEC, most recently $2.5 million sold in a notice filed in 2015.
Axsome Therapeutics at a glance
What does Axsome Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $2.5 million sold (2015).
Frequently asked questions about Axsome Therapeutics
Where is Axsome Therapeutics headquartered?
Axsome Therapeutics, Inc. is headquartered in New York, United States.
What does Axsome Therapeutics do?
Axsome Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Axsome Therapeutics a public company?
Yes. Axsome Therapeutics, Inc. trades on Nasdaq under the ticker AXSM.
When was Axsome Therapeutics founded?
The earliest incorporation on record for Axsome Therapeutics, Inc. is in 2012, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.